Sushmita “Mimi” Roy

Vice President - Technical Development, Chemistry, Manufacturing & Controls Operations Rocket Pharmaceuticals Ltd.

Leader in Biotechnology, Inventor, Translating science into improved processes and products with speed, safety, quality and patient focus, Process Development, Analytical Development, Capsid & Vector design, CRO Operations PnL & Bus Dev, Protein, Cell & Gene Therapy Cell culture, DNA Shuffling, Purification, HT Screening, Analytics & Characterization, GMP testing, CQAs, MSAT, Mass Spectrometry, BioAssays, BioPhysics, Cytometry, NMR, Bioinformatics, Nonnatural amino acid and DNA incorporation, CoInventor of Label-free proteomics, Translational Science, Biomarkers, Diagnostics, Proteomics, Target Discovery, HCP analysis and HDX, Metabolomics, Multi-site Management, Change Management, Pharmaceutical, BioTech, StartUp Environment.

Seminars

Wednesday 25th February 2026
Roundtable Discussion: Comparing Manufacturing Paradigms Between AAV & Lentiviral Vectors
3:45 pm
  • Benchmarking productivity, scalability, and cost-effectiveness between AAV and LV manufacturing systems
  • Evaluating upstream strategies: transient transfection vs. stable producer lines and implications for yield and consistency
  • Assessing downstream purification challenges: recovery, impurity clearance, and platformability
  • Identifying shared analytical standards and CQAs to ensure comparability across vector types
Sushmita Roy